Kholoud Almahzoum | Microbiology | Most Cited Article Award

Dr. Kholoud Almahzoum | Microbiology | Most Cited Article Award

General practitioners, Jaber hospital, Kuwait

Dr. Kholoud Almahzoum is a dynamic healthcare professional with a rich background in medical education, health information management, and quality improvement. Graduating with a Doctor of Medicine (MD) degree from the University of Jordan in 2024, she has over a decade of expertise in medical record management and healthcare administration. Dr. Almahzoum is the visionary founder of Kuwait Academy, a platform dedicated to fostering medical education and guiding future healthcare professionals. Recognized for her leadership in medical administration, she has been instrumental in enhancing patient outcomes and operational efficiency through collaborative and innovative approaches.

Profile 

Orcid

Education

  • Doctor of Medicine (MD) – University of Jordan (2024): A comprehensive medical education emphasizing clinical excellence and research.
  • Extensive training in health information systems, medical record management, and ICD-10 classification.
  • Certified in quality assurance and healthcare compliance standards, including Canadian accreditation protocols.
  • Specialized in implementing evidence-based practices to optimize patient care and healthcare outcomes.

Experience

  • Deputy of Head of Medical Records, Alsabah Hospital (2009-2011): Promoted evidence-based healthcare.
  • Team Leader, ICD-10 Classification, Ministry of Health (2011-2016): Led a statistical team ranking top diseases.
  • Head of Medical Department, Ibn Sina Hospital (2016-2018): Enhanced departmental efficiency and patient outcomes.
  • Team Leader, Quality Assurance, Ibn Sina Hospital (2016-2018): Achieved Canadian accreditation compliance.
  • Part-Time Teacher/Assistant, PAAET College (2016-2018): Delivered educational sessions in medical records.
  • Head, Kuwait Society University of Jordan Association (2020-2022): Organized events and supported student integration.

Research Focus

Dr. Almahzoum’s research explores intersections of technology, education, and healthcare, with a focus on:

  • Artificial Intelligence in Healthcare: Evaluating AI tools like ChatGPT in clinical and educational applications.
  • Cybersecurity Risks in Healthcare: Addressing vulnerabilities in health information systems.
  • Healthcare Education: Investigating student attitudes and usage of emerging technologies in medical learning.
  • Global Disease Trends: Statistical analysis using ICD-10 classification to understand community health patterns.

Publications

  • 🛡️ Generative Artificial Intelligence and Cybersecurity Risks: Implications for Healthcare Security Based on Real-Life Incidents
  • 🧬 The Performance of OpenAI ChatGPT-4 and Google Gemini in Virology Multiple-Choice Questions: A Comparative Analysis of English and Arabic Responses
  • 📚 Assessing Health Students’ Attitudes and Usage of ChatGPT in Jordan: Validation Study
  • 📝 Assessing Health Students’ Attitudes and Usage of ChatGPT in Jordan: Validation Study (Preprint)

Wael El-Sayed | Microbiology | Best Research Article Award

Prof Dr. Wael El-Sayed | Microbiology | Best Research Article Award

Professor, Ain Shams University, Egypt

Dr. Wael M. El-Sayed is a distinguished Professor of Toxicology and Physiology with over 30 years of experience in research, education, and mentorship. He has made significant contributions to the fields of toxicology, drug development, and molecular biology, particularly in understanding the therapeutic mechanisms of natural products. His academic journey has taken him from Cairo to Salt Lake City, and his work continues to impact the global scientific community.

Profile

Scopus

Strengths for the Award

  1. Extensive Research Experience:
    • Dr. El-Sayed has over 30 years of experience in physiology, toxicology, drug development, molecular biology, natural products, and tissue culture research. This extensive background demonstrates his deep knowledge and expertise in these fields.
  2. Diverse Research Interests:
    • His research spans a wide range of topics, including natural products, drug-drug interactions, chemoprotection strategies in cancer, antioxidants, and biochemical and molecular toxicology. This diversity reflects his ability to contribute to various research areas, which can be a significant advantage for a “Best Research Article Award.”
  3. High-Impact Publications:
    • Dr. El-Sayed has published research in reputable journals, such as Frontiers in Oncology and Journal of King Saud University – Science, which indicates the quality and relevance of his work. His recent studies on topics like the miRNome of hepatocellular carcinoma and potential COVID-19 inhibitors showcase his involvement in cutting-edge research.
  4. International Collaboration:
    • He has collaborated with researchers from different countries and institutions, including the University of Utah, USA, and King Faisal University, Saudi Arabia. This international exposure enriches his research perspectives and broadens the impact of his work.
  5. Recent and Relevant Publications:
    • The publication dates of his work, particularly in 2022 and 2023, indicate that Dr. El-Sayed is actively engaged in current research, which is crucial for winning an award for the best research article.

Areas for Improvement

  1. Focus on Breakthrough Research:
    • While Dr. El-Sayed’s research is diverse and impactful, the award committee might prioritize groundbreaking or highly innovative work. Emphasizing and furthering research that introduces novel concepts or significantly advances existing knowledge could strengthen his candidacy.
  2. Citation Impact and Recognition:
    • Although Dr. El-Sayed has published in high-quality journals, the impact of these publications, such as citation counts or recognition in the scientific community, could be further highlighted. Demonstrating the influence of his work on the field would reinforce his qualifications for the award.
  3. Enhanced Dissemination:
    • To increase the visibility and impact of his research, Dr. El-Sayed could focus on disseminating his findings through conferences, workshops, and broader media, enhancing the accessibility and application of his work beyond academic circles.

Education 🎓

Dr. El-Sayed earned his Ph.D. in Toxicology from Ain Shams University, Egypt, in collaboration with the College of Pharmacy, University of Utah, USA. His doctoral research focused on the “Mechanisms of therapeutic activities of Nigella Sativa against lipid peroxidation and hepatotoxicity in male albino rats.” Prior to this, he completed his M.Sc. in Physiology from Ain Shams University, where he explored the “Effect of Nigella Sativa on some physiological and biochemical parameters in male albino rats.” He also holds a B.Sc. in Science from Ain Shams University.

Experience 🧪

Dr. El-Sayed has held several key academic positions throughout his career. Since 2014, he has been a Professor at the Zoology Department, Faculty of Science, Ain Shams University, Cairo, Egypt. He previously served as an Associate Professor at the same department (2009-2014) and at the Biology Department, King Faisal University, Saudi Arabia (2007-2013). His early academic career includes his role as an Assistant Professor at Ain Shams University (2003-2009).

Research Interests 🔬

Dr. El-Sayed’s research spans a broad spectrum of scientific domains, including:

  • Natural products: Investigating therapeutic properties from plant and animal sources.
  • Drug-drug interactions: Understanding how drugs interact and their metabolic pathways.
  • Novel drug evaluation: Assessing the efficacy and safety of new pharmaceuticals.
  • Cancer chemoprotection: Developing strategies for cancer prevention and treatment.
  • Antioxidants: Exploring their role in health and disease.
  • Molecular toxicology: Studying the biochemical and molecular effects of toxins.

Awards 🏆

Dr. El-Sayed’s dedication to scientific research and education has earned him recognition in the academic community. His innovative work in toxicology and natural products has positioned him as a leader in his field, contributing to numerous advancements that have been acknowledged by peers and institutions worldwide.

Publications Top Notes 📚

Dr. El-Sayed has authored numerous impactful publications. Some of his recent notable works include:

miRNome of Child A hepatocellular carcinoma in Egyptian patientsFrontiers in Oncology, 2023. DOI: 10.3389/fonc.2023.1137585
Cited by multiple studies exploring hepatocellular carcinoma.

1,4,9,9-tetramethyloctahydro-4,7-(epoxymethano)azulen-5(1H)-one, a natural product as a potential inhibitor of COVID-19Journal of King Saud University – Science, 2023. DOI: 10.1016/j.jksus.2023.102628
Referenced in research on antiviral drug development.

Investigating the Antifertility Efficacy of Testosterone on Male and Female Albino MicePakistan Journal of Zoology, 2023. DOI: 10.17582/journal.pjz/20211107091104
Contributed to studies on reproductive health.

New Benzochromeno[2,3-d]pyrimidines and Benzochromenotriazolo[1,5-c]pyrimidines as Potential Inhibitors of Topoisomerase IIPolycyclic Aromatic Compounds, 2022. DOI: 10.1080/10406638.2021.2006247
Cited in cancer research for topoisomerase inhibitors.

Conclusion

Dr. Wael M. El-Sayed is a highly qualified candidate for the “Best Research Article Award,” given his extensive experience, diverse research interests, and recent high-impact publications. His work contributes significantly to the fields of toxicology, drug development, and natural products, making him a strong contender. However, to maximize his chances, he may benefit from emphasizing the novelty and broader impact of his research, as well as enhancing its visibility within the scientific community. Overall, his credentials and contributions align well with the criteria for the award, making him a suitable candidate.